Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BHA issues warning over products containing altrenogest
BHA is carrying out further work to understand the implications of this issue in Europe. 

Trace levels of anabolic steroids found in some products 

The British Horseracing Authority (BHA) is making vets and trainers aware of an international issue regarding products that contain altrenogest.

Trace levels of the anabolic steroids trenbolone and/or trendione have been detected in products containing altrenogest, which is commonly referred to by its trade name, Regumate.

Racing Victoria (Australia) has advised trainers to immediately cease using such products and further investigations are now underway.

In the UK, one such product is licensed for use in horses - Regumate Equine 2.2mg/ml Oral Solution for Horses (MSD Animal Health).

After discussions with the European manufacturer, BHA said it can confirm that the product distributed in the UK is reportedly sourced from a separate location to the products that are currently under investigation.

However, in light of the international situation, BHA is strongly advising trainers to be cautious if using altrenogest in racing thoroughbreds.

The BHA published Detection Time for altrenogest is 288 hours (15 days). In contrast, a 24-hour withdrawal from racing is recommended in Australia for mares and fillies receiving oral altrenogest.

BHA is carrying out further work to understand the implications of this issue in Europe.  

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.